Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: A phase III, open-label study (Q87412126)
Jump to navigation
Jump to search
scientific article published on 22 January 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: A phase III, open-label study |
scientific article published on 22 January 2016 |
Statements
Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: A phase III, open-label study (English)
Yoshiki Sekijima
Konen Obayashi
Taro Yamashita
Mitsuharu Ueda
Yohei Misumi
Hiroshi Morita
Katsuyuki Machii
Makoto Ohta
Ami Takata
Shû-Ichi Ikeda